Gene: TMT1B
Official Full Name: thiol methyltransferase 1Bprovided by HGNC
Gene Summary: Enables thiol S-methyltransferase activity. Predicted to be involved in methylation. Predicted to be located in cytosol; endoplasmic reticulum membrane; and lipid droplet. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13148 | TMT1B Knockout cell line (HeLa) | Human | TMT1B | 1:3~1:6 | Negative | Online Inquiry |
KO13149 | TMT1B Knockout cell line (HCT 116) | Human | TMT1B | 1:2~1:4 | Negative | Online Inquiry |
KO13150 | TMT1B Knockout cell line (HEK293) | Human | TMT1B | 1:3~1:6 | Negative | Online Inquiry |
KO13151 | TMT1B Knockout cell line (A549) | Human | TMT1B | 1:3~1:4 | Negative | Online Inquiry |
TMT1B Gene Knockout Cell Lines are specialized cellular models engineered to delete the TMT1B gene, allowing researchers to study the role of this specific gene in various biological processes. These cell lines utilize advanced CRISPR-Cas9 gene editing technology, ensuring precise and efficient knockout of the TMT1B gene, which is implicated in various physiological functions and disease mechanisms.
The primary function of TMT1B Gene Knockout Cell Lines lies in their ability to serve as a valuable tool for exploring gene function and elucidating cellular pathways. By disrupting the TMT1B gene, researchers can investigate downstream signaling pathways, correlate gene expression profiles with phenotypic changes, and identify potential therapeutic targets. This knowledge is crucial in the fields of molecular biology, genetics, and drug discovery, facilitating the development of new treatments for diseases where TMT1B expression plays a key role.
In research and clinical settings, these knockout cell lines are indispensable for understanding disease models, particularly in cancer and neurodegenerative disorders. They enable high-throughput screening of pharmacological compounds and help validate the efficacy of innovative therapeutic strategies targeting the TMT1B gene.
The specific advantages of TMT1B Gene Knockout Cell Lines compared to alternatives, such as conventional knockout models, include their robustness, reproducibility, and ease of use in various experimental assays. These cell lines provide a consistent and reliable platform for studies requiring genetic manipulation, saving time and resources for researchers.
For researchers and clinicians, the value of TMT1B Gene Knockout Cell Lines is manifold. They offer an unparalleled opportunity to conduct detailed functional studies, accelerate the pace of discovery, and drive innovations in personalized medicine. Furthermore, these cell lines come with extensive support and detailed characterization data, ensuring that users can achieve their research objectives effectively.
With a commitment to excellence and expertise in the development of cutting-edge biological products, our company is dedicated to providing high-quality gene knockout models that empower the scientific community and enhance translational research efforts.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.